Putrajaya to procure another 12.2m Pfizer vaccines

COVID-19 | Putrajaya has agreed to obtain an additional 12.2 million supply of Pfizer-BioNTech vaccine after Health Minister Dr Adham Baba signed a manufacturing and supply agreement with Pfizer Malaysia today.

With the additional 12.2 million vaccine doses which the government has agreed to obtain, Malaysia now has a total of 25 million vaccine doses which will be able to cover 39 percent of the country's population in 2021.

Meanwhile, the agreement signed today involves the procurement of the initial 12,799,800 vaccine doses which will be supplied starting the end of February.

That supply will be able to cover 20 percent of the population with two doses per person, said the Health Ministry in a statement after the signing ceremony today.

The agreement was signed virtually at the Health Ministry today between Adham, who represented the government, and Pfizer, who was represented by its country manager Luksanawan Thangpaybool.

On Jan 8, Science, Technology and Innovation Minister Khairy Jamaluddin had announced that the National Pharmaceutical Regulatory Agency (NPRA) had given the green light to the Pfizer-BioNTech Covid-19 vaccine. 

While the government was still waiting on "a few additional information" from Pfizer, Khairy said the NPRA approval means the vaccine can be used in Malaysia.

Aside from the Pfizer vaccine, the government is also procuring Covid-19 vaccines from AstraZeneca, as well as finalising deals with other manufacturers such as Sinovac, CanSino Biologics and the Gamaleya Centre.

Pfizer/BioNTech vaccine works against virus variants in lab

WHO tells rich countries to stop cutting the vaccines queue

Covid-19: Khairy says 18 months to achieve herd immunity

Pfizer vaccine given NPRA green light

Bintai Healthcare appointed exclusive distributor of vaccine storage box